Key Questions About the Current U.S. Monkeypox Outbreak
This brief answers key questions about the U.S. monkeypox outbreak to date and identifies issues that may affect the response going forward.
View the Latest: Vaccines
Filter
-
-
43% of Parents with Children Under 5 Newly Eligible for a COVID-19 Vaccine Say They Will “Definitely Not” Get Them Vaccinated
News ReleaseMost Parents Open to Getting Their Young Child Vaccinated Haven’t Yet Spoken to Their Pediatrician Most parents of young children newly eligible for a COVID-19 vaccine are reluctant to get them vaccinated, including 43% who say they will “definitely not” do so, a new KFF COVID-19 Vaccine Monitor survey finds The survey – KFF’s first…
-
KFF COVID-19 Vaccine Monitor: July 2022
Poll FindingIn the wake of the FDA's emergency use authorization for COVID-19 vaccines for children ages 6 months through 4 years old, many parents remain hesitant to vaccinate their children in this age group, with a slight majority saying they view the vaccine as a bigger risk to their child's health than getting infected with coronavirus.
-
COVID-19 Vaccination Rates Among Children Under 5 Have Peaked and Are Decreasing Just Weeks Into Their Eligibility
Issue BriefChildren between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.
-
Latest Data on COVID-19 Vaccinations by Race/Ethnicity
Issue BriefKFF is collecting and analyzing data on COVID-19 vaccinations by race/ethnicity to gain increased insight who is receiving the vaccine and whether some groups are facing disparities in vaccination.
-
The Last Major Phase of the COVID-19 Vaccination Roll-out: Children Under 5
Issue BriefWith the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.
-
KFF COVID-19 Vaccine Monitor: Pregnancy Misinformation – May 2022
Poll FindingMisinformation and confusion about the COVID-19 vaccines and pregnancy is common among women who are pregnant or planning to become pregnant, with about three in ten saying they believe at least one false statement regarding the COVID-19 vaccines.
-
Misinformation About COVID-19 Vaccines and Pregnancy is Widespread, Including Among Women Who are Pregnant or Planning to Get Pregnant
News ReleaseMisinformation and confusion about the COVID-19 vaccines and pregnancy remains widespread, with most people – including women who are pregnant or trying to get pregnant – either believing or being uncertain about at least one of three false claims they’ve heard, a new KFF COVID-19 Vaccine Monitor shows.
-
COVID-19 Vaccination Rates Among Nursing Home Staff Have Risen by 25 Percentage Points Since the Biden Administration Announced a Vaccination Mandate for Health Care Workers Last Year
News ReleaseIn a new analysis, KFF researchers find that COVID-19 vaccination rates among nursing home staff increased by 25 percentage points nationally (63% to 88%) from when the Biden administration announced the vaccine mandate for health care workers in August 2021 to after vaccination deadlines passed in March 2022.
-
Nursing Facility Staff Vaccinations, Boosters, and Shortages After Vaccination Deadlines Passed
Issue BriefThis analysis uses nursing facility-level data reported by the federal government to track the increase in vaccination rates among nursing facility staff nationally and by state between August 2021 (when the vaccine mandate was first announced) and March 27th, 2022 (after the vaccine deadline for health workers had passed in all states). Additionally, this analysis provides state-level information on booster rates among nursing home staff and the prevalence of staffing shortages after all vaccination deadlines had passed.